UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2017

 

OR

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission File Number: 000-54768

 

LOOP INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

27-2094706

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

480 Fernand Poitras Terrebonne, Quebec, Canada J6Y 1Y4

(Address of principal executive offices, including zip code) 

 

(450) 951-8555

(Registrant’s telephone number, including area code) 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x

(Do not check if a smaller reporting company)

Emerging growth company

¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act). Yes ¨ No x

 

As of July 10, 2017, the registrant had 32,674,673 shares of common stock, $0.0001 par value per share, outstanding.

 

 
 
 
 

 

LOOP INDUSTRIES, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED May 31, 2017

 

Index

 

PAGE

 

 

 

 

 

 

 

PART I. FINANCIAL INFORMATION

 

 

 

Item 1

Financial Statements

 

F-1

 

 

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

4

 

 

Item 3

Quantitative and Qualitative Disclosures About Market Risk

 

6

 

 

Item 4

Controls and Procedures

 

6

 

 

 

 

 

PART II. OTHER INFORMATION

 

 

 

Item 1

Legal Proceedings

 

7

 

 

Item 1A

Risk Factors

 

7

 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

 

7

 

 

Item 3

Defaults Upon Senior Securities

 

7

 

 

Item 4

Mine Safety Disclosures

 

7

 

 

Item 5

Other Information

 

7

 

 

Item 6

Exhibits

 

8

 

 

 

 

 

SIGNATURES

 

9

INDEX TO EXHIBITS

 

8

 
 
2
 
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q of Loop Industries, Inc., a Nevada corporation (the “Company,” “we,” or “our”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, ability to improve and expand our capabilities, competition, expected activities and expenditures as we pursue our business plan, the adequacy of our available cash resources, regulatory compliance, plans for future growth and future operations, and the size of our addressable market and market trends. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. These risks and other factors include, but are not limited to, those listed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates” included in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) and the description of material changes thereto, if any, included in our Quarterly Reports on Form 10-Q or subsequent filings with the SEC. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (i) commercialization of our technology and products, (ii) development and protection of our intellectual property and products, (iii) our need for and ability to obtain additional financing, (iv) industry competition, (v) regulatory and other legal compliance, (vi) the exercise of the control over us by Daniel Solomita, our President and Chief Executive Officer, Chairman of the Board of Directors, and majority stockholder, (vii) other factors over which we have little or no control, and (viii) other factors discussed in our filings with the SEC.

 

Our management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available.

 

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

 

We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

 
 
3
 
Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Loop Industries, Inc.

Three months ended May 31, 2017

Index to the Condensed Consolidated Financial Statements

 

Contents

Page(s)

 

Condensed Consolidated balance sheets at May 31, 2017 (Unaudited) and February 28, 2017

F-2

 

Condensed Consolidated statements of operations and comprehensive loss for the three months ended May 31, 2017 and 2016 (Unaudited)

F-3

 

Condensed Consolidated statement of changes in stockholders’ equity for the three months ended May 31, 2017 (Unaudited)

F-4

 

Condensed Consolidated statement of cash flows for the three months ended May 31, 2017 and 2016 (Unaudited)

F-5

 

Notes to the condensed consolidated financial statements

F-6

 
 
F-1
 
 

 

Loop Industries, Inc.

Condensed Consolidated Balance Sheets

 

 

 

As at

 

 

 

May 31,

2017

 

 

February 28,

2017

 

 

(Unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$ 5,535,020

 

 

$ 916,487

 

Valued added tax and other receivables

 

 

63,182

 

 

 

259,297

 

Total current assets

 

 

5,598,202

 

 

 

1,175,784

 

 

 

 

 

 

 

 

 

 

Property and Equipment, net of accumulated depreciation of $570,346 and $497,244, respectively

 

 

1,518,767

 

 

 

1,566,969

 

 

 

 

 

 

 

 

 

 

Intellectual Property, net of accumulated amortization of $152,945 and $137,050, respectively

 

 

292,105

 

 

 

308,000

 

Total assets

 

$ 7,409,074

 

 

$ 3,050,753

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$ 629,818

 

 

$ 161,536

 

Accrued officer compensation

 

 

35,156

 

 

 

360,000

 

Advances from major stockholder

 

 

-

 

 

 

391,695

 

Total current liabilities

 

 

664,974

 

 

 

913,231

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding

 

 

-

 

 

 

-

 

Common stock par value $0.0001: 250,000,000 shares authorized; 32,595,239 and 31,451,973 shares issued and outstanding, respectively

 

 

3,260

 

 

 

3,146

 

Additional paid-in capital

 

 

14,842,968

 

 

 

8,723,390

 

Common stock issuable, 1,000,000 shares at May 31 and February 28, 2017, respectively

 

 

5,500,000

 

 

 

5,500,000

 

Accumulated deficit

 

 

(13,460,893 )

 

 

(11,937,803 )

Accumulated other comprehensive loss

 

 

(141,235 )

 

 

(151,211 )

Total stockholders’ equity

 

 

6,744,100

 

 

 

2,137,522

 

Total liabilities and stockholders’ equity

 

$ 7,409,074

 

 

$ 3,050,753

 

 

See accompanying notes to the condensed consolidated financial statements.

 
 
F-2
 
Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

 

 

Three months ended

May 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Revenue

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Operating Expenses -

 

 

 

 

 

 

 

 

General and administrative

 

 

889,580

 

 

 

439,746

 

Research and development

 

 

496,538

 

 

 

415,568

 

Depreciation and amortization

 

 

90,487

 

 

 

113,024

 

Foreign exchange (gain) loss

 

 

46,485

 

 

 

(3,789 )

Total operating expenses

 

 

1,523,090

 

 

 

964,549

 

 

 

 

 

 

 

 

 

 

Net Loss

 

 

(1,523,090 )

 

 

(964,549 )

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income-

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

9,976

 

 

 

(20,493 )

Comprehensive Loss

 

$ (1,513,114 )

 

$ (985,042 )

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

- Basic and Diluted

 

$ (0.05 )

 

$ (0.03 )

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

- Basic and Diluted

 

 

31,442,283

 

 

 

30,442,256

 

 

See accompanying notes to the condensed consolidated financial statements.

 
 
F-3
 
Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

Three months ended May 31, 2017

(Unaudited)

 

 

 

Common stock par
value $0.0001

 

 

Preferred stock par
value $0.0001

 

 

Additional

 

 

Common

 

 

 

 

Accumulated Other

 

 

Total

 

 

 

Number of Shares

 

 

Amount

 

 

Number of shares

 

 

Amount

 

 

Paid-in Capital

 

 

Stock Issuable

 

 

Accumulated Deficit

 

 

Comprehensive Income (Loss)

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2017

 

 

31,451,973

 

 

$ 3,146

 

 

 

1

 

 

$ -

 

 

$ 8,723,390

 

 

$

5,500,000

 

 

$ (11,937,803 )

 

$ (151,211 )

 

$ 2,137,522

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common shares for cash

 

 

1,123,266

 

 

 

112

 

 

 

 

 

 

 

 

 

 

 

5,897,076

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,897,188

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants issued for services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

222,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

222,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of shares upon cash-less exercise of warrants

 

 

20,000

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

(2 )

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,976

 

 

 

9,976

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,523,090 )

 

 

 

 

 

 

(1,523,090 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, May 31, 2017

 

 

32,595,239

 

 

$ 3,260

 

 

 

1

 

 

$ -

 

 

$ 14,842,968

 

 

$ 5,500,000

 

 

$ (13,460,893 )

 

$ (141,235 )

 

$ 6,744,100

 

 

See accompanying notes to the condensed consolidated financial statements.

 
 
F-4
 
Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Three months ended
May 31,

 

 

 

2017

 

 

2016

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net loss

 

$ (1,523,090 )

 

$ (964,549 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation expense

 

 

74,592

 

 

 

93,921

 

Amortization expense

 

 

15,895

 

 

 

22,257

 

Fair value of warrants issued for services

 

 

222,504

 

 

 

41,359

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Valued added tax and other receivables

 

 

82,892

 

 

 

(36,804 )

Prepayments and other current assets

 

 

-

 

 

 

11,298

 

Accounts payable and accrued liabilities

 

 

468,282

 

 

 

(78,004 )

Accrued officer compensation

 

 

(324,844 )

 

 

45,000

 

Advances from majority stockholder

 

 

-

 

 

 

18,586

 

Net Cash Used in Operating Activities

 

 

(983,769 )

 

 

(846,936 )

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(55,453 )

 

 

(79,759 )

Net Cash Used in Investing Activities

 

 

(55,453 )

 

 

(79,759 )

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from sales of common shares

 

 

5,897,188

 

 

 

1,988,003

 

Repayment of advances from majority stockholder

 

 

(278,472 )

 

 

-

 

Net Cash Provided by Financing Activities

 

 

5,618,716

 

 

 

1,988,003

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes

 

 

39,039

 

 

 

(63,602 )

Net Change in Cash

 

 

4,618,533

 

 

 

997,706

 

 

 

 

 

 

 

 

 

 

Cash - beginning of period

 

 

916,487

 

 

 

422,586

 

 

 

 

 

 

 

 

 

 

Cash - end of period

 

$ 5,535,020

 

 

$ 1,420,292

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Income tax paid

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Non Cash Financing and Investing Activities

 

 

 

 

 

 

 

 

Reclassification of value added tax and other receivables to advances from majority stockholder

 

$ 113,223

 

 

$ -

 

 

See accompanying notes to the condensed consolidated financial statements.

 
 
F-5
 
Table of Contents

 

Loop Industries, Inc.

Three months ended May 31, 2017 and 2016

Notes to the Condensed Consolidated Financial Statements (Unaudited)

 

Note 1 – The Company and Basis of Presentation

 

The Company

 

Loop Holdings, Inc. was incorporated on March 11, 2010 under the laws of the State of Nevada, under the name “Radikal Phones Inc.” We changed our name to “First American Group Inc.” on October 7, 2010, and then we changed our name to our current name, “Loop Industries, Inc.”, effective July 21, 2015.

 

On June 29, 2015, Loop Industries, Inc. (the "Company" or "Loop Industries") entered into a Share Exchange Agreement (the “Share Exchange Agreement”), by and among the Company, and the holders of common stock of Loop Holdings, Inc. (“Loop Holdings”). Under the terms and conditions of the Share Exchange Agreement, the Company offered, sold and issued 23,257,500 shares of common stock in consideration for all the issued and outstanding shares in Loop Holdings. The effect of the issuance was that Loop Holdings shareholders held approximately 78.1% of the issued and outstanding shares of common stock of the Company upon consummation of the Share Exchange Agreement.

 

Pursuant to a Stock Redemption Agreement dated June 29, 2015 entered into commensurate with the share exchange, the Company redeemed 25,000,000 shares of First American Group common stock from two stockholders for an aggregate redemption price of $16,000.

 

As the former owners and management of Loop Industries had voting and operating control of the Company after the share exchange, the transaction has been accounted for as a recapitalization with Loop Holdings deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer. No step-up in basis or intangible assets or goodwill was recorded and the aggregate cost of $60,571, representing the net liabilities assumed of $35,243, cost of the redeemed shares of $16,000 and closing costs of $9,328, had been reflected as a cost of the transaction. The consolidated financial statements reflect the historical results of Loop Industries prior to the share exchange, and that of the combined company following the share exchange.

 

The Company engages in the designing, prototyping and building a closed loop plastics recycling business that leverages a proprietary depolymerization technology.

 

All references to shares of common stock in this Quarterly Report on Form 10-Q give retroactive effect to a one-for-four (1:4) reverse split of the Company’s issued and outstanding shares of common stock, which reverse split took effect on the OTCQB on September 21, 2015.

 

On May 24, 2016, 9449507 Canada Inc. was incorporated to carry on the Company’s depolymerization business. On November 11, 2016, the shares of 9449507 Canada Inc., which was wholly owned by Mr. Solomita, were transferred to Loop Industries, Inc. On December 23, 2016, 9449507 Canada Inc. changed its legal name to Loop Canada Inc. On December 31, 2016, all employees, assets, liabilities, and operations pertaining to the Company’s depolymerization business were transferred to Loop Canada Inc. from 8198381 Canada Inc., a company wholly owned by Mr. Solomita.

 

On March 9, 2017, Loop Holdings, a wholly owned subsidiary of the Company, merged with and into the Company, with the Company being the surviving entity as a result of the merger.

 
 
F-6
 
Table of Contents

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of Loop Industries, Inc. and its wholly-owned subsidiary Loop Canada Inc. (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended May 31, 2017 are not necessarily indicative of the results that may be expected for the year ending February 28, 2018.

 

Intercompany balances and transactions have been eliminated on consolidation.

 

Liquidity

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company has no recurring source of revenue and during the three months ended May 31, 2017, the Company incurred a net loss of $1,523,090 and used cash in operations of $983,769. As of May 31, 2017, the Company had cash on hand of $5,535,020 and stockholders’ equity of $6,744,100.

 

Management estimates that the current funds on hand will be sufficient to continue operations through the next twelve months. However, the Company will need additional financing through either debt or equity to finalize the transition from pilot scale to a full scale commercial manufacturing facility. Management may consider seeking additional funds, primarily through the issuance of debt and equity securities for cash and estimates that a significant amount of capital will be necessary to advance the development of our projects to the point at which they will become commercially viable.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company could obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

 

Note 2 – Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property and equipment, analysis of impairments of recorded intangibles, accruals for potential liabilities and assumptions made in calculating the fair value of certain stock instruments.

 

Foreign Currency Translations and Transactions

 

The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenses are translated at the average exchange rate of the period. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.

 
 
F-7
 
Table of Contents

 

The following table summarizes the exchange rates used:

 

 

 

Three Months

Ended May 31,

 

 

 

2017

 

 

 2016

 

Period end Canadian $: US Dollar exchange rate

 

$ 0.74

 

 

$ 0.76

 

Average period Canadian $: US Dollar exchange rate

 

$ 0.74

 

 

$ 0.78

 

 

Expenditures are translated at the average exchange rate for the period presented.

 

Value added tax, tax credits and other receivables

 

The Company is registered for the Canadian Federal and Provincial Goods and Services Taxes. As a registrant, the Company is obligated to collect, and is entitled to claim sale taxes paid on its expenses and capital expenditures incurred in Canada. As at the balance sheet date of May 31 and February 28, 2017, the computed net recoverable sale taxes amounted to $63,182 and $198,830, respectively.

 

Research and Development Costs

 

Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the three months ended May 31, 2017 and 2016 amounted to $496,538 and $415,568 respectively. Research and development costs are net of $4,472 of grant revenue received and research and development tax credit of $113,223 claimed during the period ended May 31, 2017.

 

Net Loss per Share

 

The Company computes net loss per share in accordance with FASB ASC 260 Earnings per share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the three months ended May 31, 2017 and 2016, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an anti-dilutive effect. The potentially dilutive securities consisted of 1,000,000 common shares issuable and 1,860,455 and 1,653,668 outstanding warrants as of May 31, 2017 and 2016, respectively.

 

Recently Issued Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. On August 12, 2015, FASB delayed the required implementation to fiscal years ending after December 15, 2017 but now permitted organizations such the Company to adopt earlier. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Management has determined to adopt ASU 2014-09 when it becomes effective for the Company in Fiscal 2018 and has not determined the effect of the standard on our ongoing financial reporting.

 
 
F-8
 
Table of Contents

 

In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases . ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is in the process of evaluating the impact of ASU 2016-02 on the Company’s financial statements and disclosures.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

Note 3 – Property and Equipment

 

 

Estimated

 

 

 

 

 

 

 

 

Useful

 

 

May 31,

 

 

February 28,

 

 

Life

 

 

2017

 

 

2017

 

 

(years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Machinery and Equipment

5 - 7

 

 

$ 1,591,327

 

 

$ 1,590,187

 

Office equipment and furniture

5 - 8

 

 

 

141,124

 

 

 

131,607

 

Leasehold improvements

 

3

 

 

 

356,662

 

 

 

342,419

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,089,113

 

 

 

2,064,213

 

Less: accumulated depreciation

 

 

 

 

 

(570,346 )

 

 

(497,244 )

Property and equipment, net

 

 

 

 

$ 1,518,767

 

 

$ 1,566,969

 

 

Depreciation expense for the three months ended May 31, 2017 and 2016 was $74,592 and $93,921, respectively.

 

Note 4 – Intellectual Property

 

On October 27, 2014, the Company entered into an intellectual property agreement with Mr. Hatem Essaddam (the "Intellectual Property Assignment Agreement") wherein the Company purchased a certain technique and method for $445,050 allowing for the depolymerization of polyethylene terephthalate at ambient temperature and atmospheric pressure. The Company will use such technique and know-how in its manufacturing facility. The technology is being amortized using the straight-line method over the 7 years estimated useful life of the patents.

 

In addition to the $445,050 paid by the Company under the Intellectual Property Assignment Agreement, the Company is required to make additional payments totaling CDN$800,000 to Mr. Essaddam within sixty (60) days of each of the following milestones (the “Milestones”) having been met, as follows:

 

(i)

CDN$200,000 when an average of twenty (20) metric tons per day of terephthalic acid is produced by the Company for twenty (20) operating days;

 

 

(ii)

CDN$200,000 when an average of thirty (30) metric tons per day of terephthalic acid is produced by the Company for thirty (30) operating days;

 

 

(iii)

CDN$200,000 when an average of sixty (60) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating days; and

 

 

(iv)

CDN$200,000 when an average of one hundred (100) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating days.

 

As of May 31, 2017, the Company is still in its test pilot program, none of the Milestones have been met, and accordingly no additional payments have been made.

 
 
F-9
 
Table of Contents

 

Additionally, the Company is obligated to make royalty payments of up to CDN$25,700,000, payable as follows:

 

(a)

10% of gross profits on the sale of all products derived by the Company from the technology assigned to the Company under the Intellecutal Property Assignment Agreement;

 

(b)

10% of any license fee paid to the Company in respect of any licensing or other right to use the technology assigned to the Company and granted to a third party by the Assignee;

 

(c)

5% of any royalty or other similar payment made to the Company by a third party to whom a license or other right to use the technology assigned to the Company has been granted by the Company; and

 

(d)

5% of any royalty or other similar payment made to the Company by a third party in respect of a sub-license or other right to use the technology assigned to the Company granted by the third party.

 

As of May 31, 2017, the Company has not made any royalty payments under the Intellectual Property Assignment Agreement.

 

Amortization expense is recorded as an operating expense in the consolidated statements of operations and comprehensive loss and amounted to $15,895, and $22,257 for the three months ended May 31, 2017 and 2016, respectively. As of May 31 and February 28, 2017, accumulated amortization was $152,945 and $137,050, respectively.

 

Note 5 – Related Party Transactions

 

Advances from Major Shareholder

 

Mr. Daniel Solomita, the Company’s major stockholder and CEO, or companies controlled by him, previously made advances to the Company. The advances were unsecured, non-interest bearing with no formal terms of repayment. As of February 28, 2017, the aggregate amount due to Mr. Solomita or companies controlled by him was $391,695. During the period ended May 31, 2017, the Company repaid to Mr. Solomita or companies controlled by him, as applicable, an aggregate amount of $278,472 and reclassified from value added taxes and other receivables an aggregate amount of $113,223.

 

Employment Agreement and Accrued Compensation due to Major Shareholder

 

The Company entered into an employment agreement with Daniel Solomita, the Company’s President and Chief Executive Officer for an indefinite term. During the term, the officer shall receive monthly salary of $15,000. Compensation expense under this agreement amounted to $45,000 during the three months ended May 31, 2017 and May 31, 2016. As of May 31 and February 28, 2017, accrued compensation of $35,156 and $360,000, respectively, was due to Mr. Solomita. On May 5, 2017, the total accrued compensation due to Mr. Solomita for an amount of $360,000 was paid.

 

 
F-10
 
Table of Contents

 

In addition, the Company agreed to grant the officer 4 million shares of the Company’s common stock, form of equity to be determined, if certain milestones were met.

 

Effective April 10, 2017, the Company qualified to trade on the OTCQX and began trading the same date. Accordingly, as at May 31, 2017, the officer’s entitlement to 1,000,000 shares with a fair value of $5,500,000, in aggregate, have vested. The milestones for the remaining 3,000,000 shares of common stock have not yet been met.

 

Note 6 – Stockholders’ Equity

 

Common Stock

 

During the three months ended May 31, 2017 the Company sold 1,123,266 shares of its common stock at an offering price of $5.25 per share, resulting in net proceeds to the Company of $5,897,188.

 

Warrants

 

The Company has not adopted a formal stock option plan as of May 31, 2017; however, it has made periodic non-plan grants of warrants for services and financing.

 

During the period ended May 31, 2017, the Company issued to its Chief Financial Officer a warrant to purchase up to 400,000 shares of our common stock at an exercise price of $5.25 per share, which vests quarterly in equal amounts over 24 months beginning on April 3, 2017, and have a contractual life of 10 years. This warrant had a grant date fair value of $2,331,000 as determined by a Black Scholes option pricing model and will be amortized over the vesting period. In addition, the Company issued to its Chief Financial Officer a warrant to purchase up to 150,000 additional shares of our common stock at an exercise price of $5.25 per share that will vest when certain milestones achieved. This warrant had a grant date fair value of $874,125 as determined by a Black Scholes option pricing model and will be amortized as the Company makes progress towards those milestones.

 

During the three months ended May 31, 2017, and 2016, the Company amortized $220,504, and $41,359 respectively, of these costs which are included in operating expenses. As of May 31, 2017, the unamortized balance of these costs was $3,377,143. The aggregate intrinsic value of the warrants outstanding as of May 31, 2017 was $9,325,489 calculated as the difference between the closing market price of $8.05 and the exercise price of the Company’s warrants as of May 31, 2017.

 

During the three months ended May 31, 2017 warrants to purchase an aggregate of 314,667 shares of our common stock expired.

 
 
F-11
 
Table of Contents

 

The table below summarizes the Company’s warrants activities:

 

 

 

Number of Warrant Shares

 

 

Exercise Price Range Per Share

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2017

 

 

1,647,670

 

 

$

0.80 to $6.00

 

 

$ 2.91

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

550,000

 

 

$ 5.25

 

 

$ 5.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(22,548 )

 

$ 0.80

 

 

$ 0.80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(314,667 )

 

$ 6.00

 

 

$ 6.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, May 31, 2017

 

 

1,860,455

 

 

$

0.80 to $6.00

 

 

$ 3.11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earned and exercisable, May 31, 2017

 

 

836,705

 

 

$

0.80 to $6.00

 

 

$ 2.82

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested, May 31, 2017

 

 

1,023,750

 

 

$

0.80 to $5.25

 

 

$ 3.34

 

 

For warrants requiring an assessment of value during the period of May 31, 2017, the fair value of each warrant was estimated using the Black-Scholes option pricing model with the following assumptions:

 

Risk-free interest rate

 

 

2.02 %

Expected dividend yield

 

 

0 %

Expected volatility

 

 

110.72 %

Expected life

 

6 years

 

 

As at May 31, 2017, 20,000 shares of common stock were issued as a result of a cashless exercise of 22,548 warrants with an exercise price of $0.80 per share.

 

The following table summarizes information concerning outstanding and exercisable warrants as of May 31, 2017:

 

 

 

 

Warrants Outstanding

 

 

Warrants Exercisable

 

Range of Exercise Prices

 

 

Number Outstanding

 

 

Average Remaining Contractual Life (in years)

 

 

Weighted Average Exercise Price

 

 

Number Exercisable

 

 

Average Remaining Contractual Life (in years)

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.80

 

 

 

912,452

 

 

 

0.51

 

 

$ 0.80

 

 

 

507,452

 

 

 

0.51

 

 

$ 0.80

 

$

6.00

 

 

 

323,003

 

 

 

0.08

 

 

$ 6.00

 

 

 

323,003

 

 

 

0.08

 

 

$ 6.00

 

$

3.00

 

 

 

75,000

 

 

 

1.02

 

 

$ 3.00

 

 

 

6,250

 

 

 

1.02

 

 

$ 3.00

 

$

5.25

 

 

 

550,000

 

 

 

9.98

 

 

$ 5.25

 

 

 

-

 

 

 

-

 

 

$ -

 

    

 
F-12
 
Table of Contents

 

Note 7 – Geographic Information

 

As of May 31, 2017 and 2016, the Company had two reportable diverse geographical concentrations, the United States and Canada. Information related to these operating segments, net of eliminations, consists of the following for the periods below:

 

 

 

Three months ended
May 31, 2017

 

 

 

 

 

 

United States

 

 

Canada

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$ -

 

 

$ -

 

 

$ -

 

Cost of revenue

 

 

-

 

 

 

-

 

 

 

-

 

General and administrative

 

 

482,455

 

 

 

407,125

 

 

 

889,580

 

Research and development

 

 

57,768

 

 

 

438,770

 

 

 

496,538

 

Depreciation and amortization

 

 

25,961

 

 

 

64,526

 

 

 

90,487

 

Foreign exchange loss (gain)

 

 

-

 

 

 

46,485

 

 

 

46,485

 

Loss from operations

 

$ (566,184 )

 

$ (956,906 )

 

$ (1,523,090 )

 

 

 

As at

May 31, 2017

 

 

 

 

 

 

United States

 

 

Canada

 

 

 Total

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

$ 4,571,525

 

 

$ 1,026,677

 

 

$ 5,598,202

 

Property and equipment, net

 

 

147,328

 

 

 

1,371,439

 

 

 

1,518,767

 

Intangible assets, net

 

 

292,105

 

 

 

-

 

 

 

292,105

 

Total assets

 

$ 5,010,958

 

 

$ 2,398,116

 

 

$ 7,409,074

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

$ 230,962

 

 

$ 434,012

 

 

$ 664,974

 

Equity

 

 

8,547,511

 

 

 

(1,803,411 )

 

 

6,744,100

 

Total liabilities and equity

 

$ 8,778,473

 

 

$ (1,369,399 )

 

$ 7,409,074

 

 
 
F-13
 
Table of Contents

 

 

 

Three months ended
May 31, 2016

 

 

 

 

 

 

United States

 

 

Canada

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$ -

 

 

$ -

 

 

$ -

 

Cost of revenue

 

 

-

 

 

 

-

 

 

 

-

 

General and administrative

 

 

231,797

 

 

 

207,949

 

 

 

439,746

 

Research and development

 

 

149,674

 

 

 

265,894

 

 

 

415,568

 

Depreciation and amortization

 

 

33,924

 

 

 

79,100

 

 

 

113,024

 

Foreign exchange loss (gain)

 

 

-

 

 

 

(3,789 )

 

 

(3,789 )

Loss from operations

 

$ (415,395 )

 

$ (549,154 )

 

$ (964,549 )

 

 

 

As at

May 31, 2016

 

 

 

 

 

 

United States

 

 

Canada

 

 

 Total

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

$ 1,374,929

 

 

$ 360,038

 

 

$ 1,734,967

 

Property and equipment, net

 

 

146,746

 

 

 

1,281,554

 

 

 

1,428,300

 

Intangible assets, net

 

 

349,322

 

 

 

-

 

 

 

349,322

 

Total assets

 

$ 1,870,997

 

 

$ 1,641,592

 

 

$ 3,512,589

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

$ 335,483

 

 

$ 715,308

 

 

$ 1,050,791

 

Equity

 

 

4,185,534

 

 

 

(1,723,736 )

 

 

2,461,798

 

Total liabilities and equity

 

$ 4,521,017

 

 

$ (1,008,428 )

 

$ 3,512,589

 

 

Note 8 – Subsequent Event

 

On June 30, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of options to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were reserved for issuance under the Plan with an automatic share reserve increase, as defined in the Plan, effective commencing March 1, 2018. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of stock options granted, the share price pursuant to the stock options and the vesting conditions and period. The options, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the option will not exceed 5 years.

 

 
F-14
 
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following information should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q and the audited financial information and the notes thereto included in our most recent Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission, or the SEC, on May 30, 2017.

 

The following information and any forward-looking statements should be considered in light of factors discussed elsewhere in this Quarterly Report on Form 10-Q, including those risks identified in the “Risk Factors” section of our most recent Annual Report on Form 10-K.

 

Overview

 

Our business develops technology and processes to promote the regeneration and reuse of materials to sustain a circular economy.

 

Currently, the focus of our business is on the depolymerizing waste PET plastics and converting them into valuable chemicals, ready to be reintroduced into the manufacturing of virgin PET plastic. Our proprietary technology breaks down PET into its base chemicals, PTA and MEG, at a recovery rate of over 90% and under normal atmospheric pressure and at room temperature.

 

Depolymerization presents two unique advantages in recycling resin-based products: (i) the ability to return a recovered resin to virgin-resin-like quality, and (ii) the potential to recover a valuable feedstock from products that are economically challenging to recycle. When plastic is mechanically recycled, even small levels of contamination can compromise the performance of the resin. However, because depolymerization breaks down plastics into monomer form, all contamination is removed. Our unique depolymerization process can be applied to all sorts of post-consumer PET, including degraded, colored or heavily contaminated PET that is not currently recyclable.

 

We are a development-stage company and have never generated any revenues. Our depolymerization technology must be scaled-up before we can commercialize the technology and generate any revenues. We intend to sell depolymerized LOOP™-branded PET resin to sustainably focused customers. During January 2016, we announced the successful completion of a pilot plant facility in Montreal, Canada with a production capacity of 2.5 metric tons per day of high purity PTA and MEG.

 

Plan of Operation

 

We are planning to and have begun taking steps to build a commercial scale facility with an installed capacity of a minimum of 10,000 metric tons (MT) per annum to supply our potential customers with LOOP™ branded PET resin of up to 50% recycled content. We are planning to finance any new facilities through additional sales of our common stock, government assistance, including grants and low-interest loans and traditional bank financing.

 

We are conducting qualification testing of our LOOP™ branded PET resin and negotiating long term supply contracts with potential customers. In addition, we are optimizing our manufacturing process to ensure a smooth transition from pilot scale to full scale commercial manufacturing facility.

 

Our plan of operation also includes the development of the LOOP™ branded PET resin, by establishing co-marketing and co-branding initiatives with potential customers. LOOP™ branded PET resin will primarily focus on educating consumers on the importance of the circular economy and the Loop technology that can play a pivotal role in this new economy.

 

Results of Operations

 

For the three months ended May 31, 2017 and May 31, 2016

 

We recorded no revenues for the three months ended May 31, 2017 and May 31, 2016.

 

We realized a net loss from operations of $1.5 million for the three months ended May 31, 2017 compared to a net loss of $1.0 million for the three months ended May 31, 2016. This net loss from operations is mainly due to an increase in general and administrative expenses of $0.9 million for the period ended May 31, 2017 compared to $0.4 million for the period ended May 31, 2016. In addition, we incurred $0.5 million in research and development expenses for the period ended May 31, 2017 compared to $0.4 million for the period ended May 31, 2016 as we continue to scale our technology.

 
 
4
 
Table of Contents

 

Activity in the three months ended May 31, 2017 continues to focus on the development of plans for a commercial facility, continued testing and improvement of our depolymerization process as well as testing of various feedstocks used in the depolymerization process.

 

On the commercial side, we have undertaken various marketing initiatives to raise awareness of the Loop depolymerization process. In addition, we have been working with future customers and other key stakeholders to ensure that the Loop™ branded PET resin meets customers’ needs and specifications once commercial production begins.

 

Liquidity and Capital Resources

 

As reflected in the accompanying consolidated financial statements, we have no recurring source of revenue and during the three months ended May 31, 2017, we incurred a net loss of $1.5 million and used cash in operations of $1.0 million. As of May 31, 2017, we had cash on hand of $5.5 million and stockholders’ equity of $6.7 million as a result of the sale of 1,123,266 shares of our common stock on May 4, 2017 for net proceeds of $5.9 million.

 

We estimate that the current funds on hand will be sufficient to continue operations through the next twelve months. However, we will need additional financing through either debt or equity to finalize the transition from pilot scale to a full scale commercial manufacturing facility. We are currently seeking additional funds, primarily through the issuance of debt and equity securities for cash and estimates that a significant amount of capital will be necessary to advance the development of our projects to the point at which they will become commercially viable.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to us. Even if we could obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.

 

Off-Balance Sheet Arrangements

 

As of May 31, 2017, we did not have any off-balance sheet arrangements as defined in the rules and regulations of the SEC.

 
 
5
 
Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Management’s Evaluation of our Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and the Chief Financial Officer, we are responsible for conducting an evaluation of the effectiveness of the design and operation of our internal controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the fiscal quarter covered by this report. Disclosure controls and procedures means that the material information required to be included in our SEC reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, including any consolidating subsidiaries, and was made known to us by others within those entities, particularly during the period when this report was being prepared. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were effective as of May 31, 2017.

 

Changes in Internal Control over Financial Reporting

 

As described under “Material Weakness Discussion and Remediation” in our most recent Annual Report on Form 10-K, filed on May 30, 2017, we have undertaken a broad range of remedial procedures to address the weaknesses in our internal control over financial reporting. Testing of the effectiveness of these remediation efforts will be undertaken in future quarters.

 
 
6
 
Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. As of May 31, 2017, no legal proceedings, government actions, administrative actions, investigations or claims are pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business, financial condition or operating results. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

We anticipate that we will expend significant financial and managerial resources in the defense of our intellectual property rights in the future if we believe that our rights have been violated. We also anticipate that we will expend significant financial and managerial resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

 

ITEM 1A. RISK FACTORS.

 

We are subject to various risks and uncertainties in the course of our business. Risk factors relating to us are set forth under “Risk Factors” in our Annual Report on Form 10-K, filed on May 30, 2017. No material changes to such risk factors have occurred during the three months ended May 31, 2017.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Issuance of Warrants

 

Pursuant to the employment agreement with our chief financial officer D. Jennifer Rhee, dated March 17, 2017, we issued a warrant to purchase up to 400,000 shares of our common stock at a price per share of $5.25, that shall vest quarterly, in equal amounts, over a 24-month period beginning on April 3, 2017 and a warrant to purchase up to 150,000 shares of our common stock at a price per share of $5.25 that shall vest upon the achievement of certain milestones. The warrants were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

 

A copy of the employment agreement and the form of warrant are attached as Exhibit 10.2 and Exhibit 4.2, respectively, to this quarterly report and are incorporated herein by reference.

 

Exercise of Warrants

 

We also issued 20,000 shares of our common stock upon the cash-less exercise of 22,548 warrants with an exercise price of $0.80 per share. The shares and the warrants were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

None.

 
 
7
 
Table of Contents

 

ITEM 6. EXHIBITS.

 

The following Exhibits, as required by Item 601 of Regulation S-K, are attached or incorporated by reference, as stated below.

 

Exhibit Index

 

 

Incorporated by Reference  

Number

 

Description

 

Form

 

File No.

 

Filing Date

 

Exhibit No.

3.1

 

Articles of Incorporation

 

10-K

 

000-54768

 

May 30, 2017

 

3.1

3.2

 

By-laws

 

S-1

 

333-171091

 

Dec 10, 2010

 

3.2

4.1

 

Form of Common Stock Subscription Agreement

 

8-K

 

000-54768

 

May 5, 2017

 

10.1

4.2

 

Form of Warrant

 

Filed herewith

 

10.1

 

Articles of Merger of Loop Holdings, Inc. into Loop Industries, Inc.

 

10-K

 

000-54768

 

May 30, 2017

 

10.9

10.2

 

Employment Agreement, dated March 17, 2017, by and between D. Jennifer Rhee and Loop Industries, Inc.

 

Filed herewith

 

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

Filed herewith

 

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

Filed herewith

 

32.1

 

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

Furnished herewith

 

32.2

 

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

Furnished herewith

 

101.INS

 

XBRL Instance Document

 

Filed herewith

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

Filed herewith

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

Filed herewith

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

Filed herewith

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

Filed herewith

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

Filed herewith

 
 
8
 
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

LOOP INDUSTRIES, INC.

     

 

Date: July 14, 2017

By:

/s/ Daniel Solomita

 

Name:

Daniel Solomita

 

Title:

President and Chief Executive Officer

(principal executive officer)

 

 

Date: July 14, 2017

By:

/s/ D. Jennifer Rhee

 

Name:

D. Jennifer Rhee

 

Title:

Chief Financial Officer (principal accounting

officer and principal financial officer)

 

 

 

9

 

EXHIBIT 4.2

 

LOOP INDUSTRIES, INC.

 

STAND-ALONE COMPENSATORY WARRANT AGREEMENT

 

I. NOTICE OF COMPENSATORY WARRANT GRANT

 

Name:

 

Address:

 

The undersigned Participant has been granted a Warrant to purchase Common Stock of the Company, subject to the terms and conditions of this Agreement, as follows:

 

Date of Grant:

 

 

Vesting Commencement Date:

 

 

Exercise Price per Share:

 

 

Total Number of Shares Granted:

 

 

Total Exercise Price:

 

 

Type of Warrant:

Nonstatutory Stock Option

 

 

Term/Expiration Date:

10-year anniversary of Date of Grant

 

 

Vesting Schedule :

 

 

This Warrant shall be exercisable, in whole or in part, according to the following vesting schedule:

 

·      [TO BE PROVIDED]

 

 

Accelerated Vesting :

 

 

·     [TO BE PROVIDED]

 

 

Termination Period :

 

This Warrant shall be exercisable for three (3) months after Participant ceases to be a Service Provider in accordance with Sections 9 of this Agreement, unless such termination is due to Participant’s death or Disability, in which case this Warrant shall be exercisable for twelve (12) months after Participant ceases to be a Service Provider in accordance with Sections 10 and 11 of this Agreement. Notwithstanding the foregoing sentence, in no event may this Warrant be exercised after the Term/Expiration Date as provided above and this Warrant may be subject to earlier termination as provided in Section II.12 of this Agreement.

 

 
-1-
 
 

 

II. AGREEMENT

 

1. Definitions . As used herein, the following definitions shall apply:

 

(a) “ Agreement ” means this compensatory warrant agreement between the Company and Participant evidencing the terms and conditions of this Warrant.

 

(b) “ Applicable Laws ” means the requirements relating to the administration of equity-based awards under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction that may apply to this Warrant.

 

(c) “ Board ” means the Board of Directors of the Company or any committee of the Board of Directors of the Company that has been designated by the Board to administer this Agreement. The Board has full authority and discretion to administer this Agreement, including but not limited to the authority to: (i) modify or amend the Warrant (subject to Section 21 of this Agreement), including, but not limited to, the discretionary authority to extend the post-termination exercise period of the Warrant, (ii) authorize any person to execute on behalf of the Company any instrument required to effect the grant or amendment of the Warrant previously granted or amended by the Board, (iii) provide for the transferability of the Warrant, and (iv) construe and interpret the terms of the Warrant. All decisions, determinations and interpretations of the Board shall be final and binding on the Participant.

 

(d) “ Change of Control ” has the meaning ascribed to it in the Employment Agreement.

 

(e) “ Code ” means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein shall be a reference to any successor or amended section of the Code.

 

(f) “ Common Stock ” means the common stock of the Company.

 

(g) “ Company ” means Loop Industries, Inc., a Nevada corporation, or any successor thereto.

 

(h) “ Consultant ” any natural person, including an advisor, engaged by the Company or a Parent or Subsidiary to render bona fide services to such entity, provided the services (i) are not in connection with the offer or sale of securities in a capital‑raising transaction, and (ii) do not directly promote or maintain a market for the Company’s securities.

 

(i) “ Director ” means a member of the Board.

 

(j) “ Disability ” means total and permanent disability as defined in Section 22(e)(3) of the Code.

 

 
-2-
 
 

 

(k) “ Employee ” means any person, including officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. Participant shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company or between the Company, its Parent, any Subsidiary, or any successor. Neither service as a Director nor payment of a director’s fee by the Company shall be sufficient to constitute “employment” by the Company.

 

(l) “ Employment Agreement ” means Participant’s Employment Agreement with the Company dated March 17, 2017, as it may be amended from time to time.

 

(m) “ Exchange Act ” means the Securities Exchange Act of 1934, as amended.

 

(n) “ Exchange Program ” means a program under which (i) the outstanding Warrant is surrendered or cancelled in exchange for warrants of the same type (which may have lower or higher exercise prices and different terms), awards of a different type, and/or cash, and/or (ii) Participant would have the opportunity to transfer the outstanding Warrant to a financial institution or other person or entity selected by the Board, and/or (iii) the exercise price of the outstanding Warrant is reduced or increased. The terms and conditions of any Exchange Program shall be determined by the Board in its sole discretion. An Exchange Program can be entered into with respect to the Warrant if agreed to in writing by the Participant and the Company.

 

(o) “ Fair Market Value ” means, as of any date, the value of Common Stock determined as follows:

 

(i) If the Common Stock is listed on any established stock exchange or a national market system (other than an over-the-counter market, which will not be considered an established stock exchange or national market system for the purposes of this definition), including without limitation the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market Value will be the closing sales price for such stock (or if no closing sales price was reported on that date, as applicable, on the last trading date such closing sales price was reported) as quoted on such exchange or system on the day of determination, as reported in The Wall Street Journal or such other source as the Board deems reliable;

 

(ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and asks were reported), as reported in The Wall Street Journal or such other source as the Board deems reliable; or

 

(iii) In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Board.

 

(p) “ Nonstatutory Stock Option ” means a Warrant not intended to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.

 

(q) “ Notice of Grant ” means a written notice, in Part I of this Agreement, evidencing certain terms and conditions of this Warrant grant. The Notice of Grant is part of the Agreement.

 

 
-3-
 
 

 

(r) “ Parent ” means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code.

 

(s) “ Participant ” means the person named in the Notice of Grant or such person’s successor.

 

(t) “ Securities Act ” means the Securities Act of 1933, as amended.

 

(u) “ Service Provider ” means an Employee, Director or Consultant.

 

(v) “ Share ” means a share of the Common Stock, as adjusted in accordance with Section 12 of this Agreement.

 

(w) “ Subsidiary ” means a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f) of the Code.

 

(x) “ Warrant ” means this compensatory warrant to purchase shares of Common Stock granted pursuant to this Agreement.

 

2. Grant of Warrant . The Board hereby grants to the Participant named in the Notice of Grant attached as Part I of this Agreement the Warrant to purchase the number of Shares, as set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the “Exercise Price”), subject to the terms and conditions of this Agreement.

 

3. Exercise of Warrant .

 

(a) Right to Exercise . This Warrant shall be exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Grant and the applicable provisions of this Agreement. Vesting of the Warrant shall be suspended during any unpaid leave of absence, unless the Board provides otherwise or continued vesting during such leave of absence is required by Applicable Law.

 

(b) Method of Exercise . This Warrant shall be exercisable by delivery of an exercise notice, in the form attached as Exhibit A (the “Exercise Notice”) or in a manner and pursuant to such procedures as the Board may determine, which shall state the election to exercise the Warrant, the number of Shares with respect to which the Warrant is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares, together with any applicable tax withholding. This Warrant shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with any applicable tax withholding.

 

(c) Legal Compliance . No Shares shall be issued pursuant to the exercise of this Warrant unless such issuance and such exercise comply with Applicable Laws. Assuming such compliance, for income tax purposes the Exercised Shares shall be considered transferred to Participant on the date on which the Warrant is exercised with respect to such Exercised Shares.

 

 
-4-
 
 

 

4. Participant’s Representations . In the event the Shares have not been registered under the Securities Act, at the time this Warrant is exercised, Participant shall, if required by the Company, concurrently with the exercise of all or any portion of this Warrant, deliver to the Company his or her Investment Representation Statement in the form attached hereto as Exhibit B .

 

5. Method of Payment . Payment of the aggregate Exercise Price shall be by any of the following, or a combination thereof, at the election of Participant:

 

(a) cash;

 

(b) check;

 

(c) consideration received by the Company under a cashless exercise program implemented by the Company;

 

(d) surrender of other Shares which (i) shall be valued at its Fair Market Value on the date of exercise, and (ii) must be owned free and clear of any liens, claims, encumbrances or security interests, if accepting such Shares, in the sole discretion of the Board, shall not result in any adverse accounting consequences to the Company; or

 

(e) any combination of the foregoing methods of payment.

 

6. Non-Transferability of Warrant .

 

(a) This Warrant may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant. The terms of this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of Participant.

 

(b) Further, until the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, or after the Administrator determines that it is, will, or may no longer be relying upon the exemption from registration of Options under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act (the “Rule 12h-1(f) Exemption”) (such date, the “Reliance End Date”), Participant shall not transfer this Option or, prior to exercise, the Shares subject to this Option, in any manner other than (i) to persons who are “family members” (as defined in Rule 701(c)(3) of the Securities Act) through gifts or domestic relations orders, or (ii) to an executor or guardian of Participant upon the death or disability of Participant in each case, to the extent required for continued reliance on the Rule 12h-1(f) Exemption. Until the Reliance End Date, the Options and, prior to exercise, the Shares subject to this Option, may not be pledged, hypothecated or otherwise transferred or disposed of, including by entering into any short position, any “put equivalent position” or any “call equivalent position” (as defined in Rule 16a-1(h) and Rule 16a-1(b) of the Exchange Act, respectively), other than as permitted in clauses (i) and (ii) of this paragraph. Notwithstanding the foregoing sentence, the Administrator, in its sole discretion, may determine to permit transfers to the Company or in connection with a Change in Control or other acquisition transactions involving the Company to the extent permitted by Rule 12h-1(f) or, if the Company is not relying on the Rule 12h-1(f) Exemption, to the extent permitted by the Plan.

 

 
-5-
 
 

 

7. Rights as a Stockholder . Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Shares subject to the Warrant, notwithstanding the exercise of the Warrant. The Company shall issue (or cause to be issued) such Shares promptly after the Warrant is exercised. No adjustment shall be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 12 below.

 

8. Term of Warrant . Subject to Sections 9, 10 and 11 this Warrant may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the terms of this Agreement.

 

9. Termination of Relationship as a Service Provider . If Participant ceases to be a Service Provider, other than upon Participant’s death or Disability, the Warrant shall remain exercisable for three (3) months following Participant’s termination (but in no event later than the Warrant’s Expiration Date or as provided in Section 12). In that event, the Warrant shall be exercisable only to the extent that the Warrant was unexercised and vested on the date of termination. Unless the Board provides otherwise, if on the date of termination the Participant is not vested as to his or her entire Warrant, the unvested portion of the Warrant shall terminate and Participant shall have no further rights to acquire the Shares subject thereto. If, after termination, the Participant does not exercise his or her Warrant within the time specified herein, the Warrant shall terminate and Participant shall have no further rights to acquire the Shares subject thereto.

 

10. Disability of Participant . If Participant ceases to be a Service Provider as a result of Participant’s Disability, the Warrant may be exercised for a period of twelve (12) months after the date of such termination (but in no event later than the expiration date of the Warrant as set forth in the Notice of Grant or as provided in Section 12 to the extent that the Warrant is vested on the date of such termination). Unless the Board provides otherwise, if on the date of termination the Participant is not vested as to his or her entire Warrant, the unvested portion of the Warrant shall terminate and Participant shall have no further rights to acquire the Shares subject thereto. If, after termination, the Participant does not exercise his or her Warrant within the time specified herein, the Warrant shall terminate and Participant shall have no further rights to acquire the Shares subject thereto.

 

11. Death of Participant . If Participant dies while a Service Provider, the Warrant may be exercised at any time within twelve (12) months following the date of death (but in no event later than the expiration date of the Warrant as set forth in the Notice of Grant or as provided in Section 12, by Participant’s estate or by a person who acquired the right to exercise the Warrant by bequest or inheritance, but only to the extent that Participant was entitled to exercise the Warrant at the date of death. If on the date of death the Participant is not vested as to his or her entire Warrant, the unvested portion of the Warrant shall terminate and Participant’s estate or the person who acquired the right to exercise the Warrant by bequest or inheritance shall have no further rights to acquire the Shares subject thereto. If, after death, Participant’s estate or a person who acquired the right to exercise the Warrant by bequest or inheritance does not exercise the Warrant within the time specified herein, the Warrant shall terminate.

 

 
-6-
 
 

 

12. Adjustments; Dissolution or Liquidation; Merger or Change in Control .

 

(a) Changes in Capitalization . In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs, the Board, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Warrant, shall adjust the number, class, and price of Shares covered by the Warrant.

 

(b) Dissolution or Liquidation . In the event of the proposed dissolution or liquidation of the Company, the Board shall notify Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, the Warrant shall terminate immediately prior to the consummation of such proposed action.

 

(c) Merger or Change of Control . In the event of a merger or Change of Control, the Warrant will be treated as the Board determines (subject to the Accelerated Vesting provisions set forth in the Notice of Grant) without Participant’s consent, including, without limitation, that (i) the Warrant will be assumed, or a substantially equivalent Warrant will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and prices; (ii) upon written notice to Participant, that Participant’s Warrant will terminate upon or immediately prior to the consummation of such merger or Change in Control; (iii) the Warrant will vest and become exercisable in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the extent the Board determines, terminate upon or immediately prior to the effectiveness of such merger or Change in Control; (iv) (A) the termination of the Warrant in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of the Warrant as of the date of the occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Board determines in good faith that no amount would have been attained upon the exercise of the Warrant, then the Warrant may be terminated by the Company without payment), or (B) the replacement of the Warrant with other rights or property selected by the Board in its sole discretion; or (v) any combination of the foregoing. In taking any of the actions permitted under this Section 12(c), the Board will not be obligated to treat all awards, all awards held by Participant, or all awards of the same type, similarly.

 

13. Inability to Obtain Authority . The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

 

14. Notices . Any notice to be given to the Company hereunder shall be in writing and shall be addressed to the Company at its then current principal executive office or to such other address as the Company may hereafter designate to Participant by notice as provided in this section. Any notice to be given to Participant hereunder shall be addressed to Participant at the address set forth beneath his signature hereto, or at such other address as Participant may hereafter designate to the Company by notice as provided herein. A notice shall be deemed to have been duly given when personally delivered or mailed by registered or certified mail to the party entitled to receive it.

 

 
-7-
 
 

 

15. Tax Obligations .

 

(a) Tax Withholding . Participant agrees to make appropriate arrangements with the Company (or the Parent or Subsidiary employing or retaining Participant) for the satisfaction of all tax and/or social insurance liability obligations and requirements in connection with the Warrant, including, without limitation, (a) all income, employment and local taxes that the Company or the Service Recipient determines are required to be withheld by the Company or the Service Recipient or other payment of tax-related items related to the Warrant and legally applicable to Participant, (b) the Participant’s and, to the extent required by the Company (or Service Recipient), the Company’s (or Service Recipient’s) fringe benefit tax liability, if any, associated with the grant, vesting, or exercise of the Warrant or sale of Shares, and (c) any other Company (or Service Recipient) taxes the responsibility for which the Participant has, or has agreed to bear, with respect to the Warrant (or exercise thereof or issuance of Shares thereunder) (collectively, the “Tax-Related Items”) which the Company determines must be withheld in connection with the Warrant. Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant’s employer (the “Employer”) or Parent or Subsidiary to which Participant is providing services (together, the Company, Employer, and/or Parent or Subsidiary to which the Participant is providing services, the “Service Recipient”) the ultimate liability for all Tax-Related Items, is and remains Participant’s responsibility and may exceed the amount actually withheld by the Service Recipient. Participant acknowledges that the Service Recipient (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Warrant, including, but not limited to, the grant, vesting or exercise of the Warrant, the subsequent sale of Exercised Shares and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of this Warrant to reduce or eliminate Participant’s liability for Tax-Related Items or achieve any particular tax result. Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise. Further, if Participant is subject to Tax-Related Items in more than one jurisdiction between the date of grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Service Recipient (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. Prior to the relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate arrangements satisfactory to the Service Recipient to satisfy all Tax-Related Items.

 

(b) The Board, in its sole discretion and pursuant to such procedures as it may specify from time to time, and Participant authorizes the Service Recipient and its agents to take all necessary or appropriate action, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following, if permissible by applicable local law: (i) paying cash, (ii) electing to have the Company or the Service Recipient withhold otherwise deliverable Shares having a Fair Market Value equal to the amount of such Tax-Related Items, (iii) withholding the amount of such Tax-Related Items from Participant’s wages or other cash compensation paid to Participant by the Service Recipient, (iv) if Participant is a U.S. employee, delivering to the Company already vested and owned Shares having a Fair Market Value equal to such Tax-Related Items, or (v) by selling a sufficient number of such Exercised Shares, or Shares otherwise deliverable to Participant through such means, either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization without further consent) as the Company may determine in its sole discretion (whether through a broker or otherwise) equal to the amount of the Tax-Related Items. To the extent determined appropriate by the Company in its discretion, it will have the right (but not the obligation) to satisfy any Tax-Related Items by reducing the number of Shares otherwise deliverable to Participant. The Fair Market Value of any Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined. All elections by Participant to have Shares withheld for this purpose shall be made in such form and under such conditions as the Board may deem necessary or advisable. Finally, Participant agrees to pay to Service Recipient any amount of Tax-Related Items that the Service Recipient may be required to withhold or account for as a result of this Agreement and the Warrant hereunder that cannot be satisfied by the means previously described.

 

 
-8-
 
 

 

(c) Code Section 409A. To the extent Participant is or becomes subject to U.S. Federal income taxation, this subsection (c) shall apply. Under Code Section 409A, a stock right (such as the Warrant) that vests after December 31, 2004 (or that vested on or prior to such date but which was materially modified after October 3, 2004) that was granted with a per share exercise price that is determined by the Internal Revenue Service (the “IRS”) to be less than the fair market value of an underlying share on the date of grant (a “discount option”) may be considered “deferred compensation.” A stock right that is a “discount option” may result in (i) income recognition by the recipient of the stock right prior to the exercise of the stock right, (ii) an additional twenty percent (20%) federal income tax, and (iii) potential penalty and interest charges. The “discount option” may also result in additional state income, penalty and interest tax to the recipient of the stock right. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Warrant equals or exceeds the fair market value of a Share on the date of grant in a later examination. Participant agrees that if the IRS determines that the Warrant was granted with a per Share exercise price that was less than the fair market value of a Share on the date of grant, Participant shall be solely responsible for Participant’s costs related to such a determination.

 

16. Nature of Grant . In accepting the Warrant, Participant acknowledges, understands and agrees that:

 

(a) the grant of the Warrant is voluntary and occasional and does not create any contractual or other right to receive future grants of options or warrants, or benefits in lieu of options or warrants, even if options or compensatory warrants have been granted in the past;

 

(b) all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company;

 

(c) Participant is voluntarily participating in this Agreement;

 

(d) the Warrant and any Shares acquired under this Agreement are not intended to replace any pension rights or compensation;

 

(e) the Warrant and Shares acquired under this Agreement and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;

 

 
-9-
 
 

 

(f) the future value of the Shares underlying the Warrant is unknown, indeterminable, and cannot be predicted with certainty;

 

(g) if the underlying Shares do not increase in value, the Warrant will have no value;

 

(h) if Participant exercises the Warrant and acquires Shares, the value of such Shares may increase or decrease in value, even below the Exercise Price;

 

(i) for purposes of the Warrant, Participant’s engagement as a Service Provider will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Parent or Subsidiary (regardless of the reason for such termination and whether or not later found to be invalid or in breach of applicable laws in the jurisdiction where Participant is a Service Provider or the terms of Participant’s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement (including by reference in the Notice of Grant to other arrangements or contracts) or determined by the Board, (i) Participant’s right to vest in the Warrant, if any, will terminate as of such date and will not be extended by any notice period ( e.g ., Participant’s period of service would not include any contractual notice period or any period of “garden leave” or similar period mandated under applicable laws in the jurisdiction where Participant is a Service Provider or Participant’s employment or service agreement, if any, unless Participant is providing bona fide services during such time); and (ii) the period (if any) during which Participant may exercise the Warrant after such termination of Participant’s engagement as a Service Provider will commence on the date Participant ceases to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant’s engagement agreement, if any; the Board shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of this Warrant grant (including whether Participant may still be considered to be providing services while on a leave of absence);

 

(j) unless otherwise provided by the Company in its discretion, the Warrant and the benefits evidenced by this Agreement do not create any entitlement to have the Warrant or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and

 

(k) the following provisions apply only if Participant is providing services outside the United States:

 

 

(i) the Warrant and the Shares subject to the Warrant are not part of normal or expected compensation or salary for any purpose;

 

 

 

 

(ii) Participant acknowledges and agrees that none of the Company, the Service Recipient, or any Parent or Subsidiary shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the Warrant or of any amounts due to Participant pursuant to the exercise of the Warrant or the subsequent sale of any Shares acquired upon exercise; and

 

 
-10-
 
 

 

 

(iii) no claim or entitlement to compensation or damages shall arise from forfeiture of the Warrant resulting from the termination of Participant’s engagement as a Service Provider (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is a Service Provider or the terms of Participant’s employment or service agreement, if any), and in consideration of the grant of the Warrant to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, any Parent, any Subsidiary or the Service Recipient, waives its ability, if any, to bring any such claim, and releases the Company, any Parent or Subsidiary and the Service Recipient from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by executing this Agreement, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim.

 

17. No Advice Regarding Grant . The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in this Agreement, or Participant’s acquisition or sale of the underlying Shares. Participant is hereby advised to consult with its own tax, legal and financial advisors regarding its participation in this Agreement before taking any action related to this Agreement.

 

18. Data Privacy . Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other option grant materials by and among, as applicable, the Employer or other Service Recipient, the Company and any Parent or Subsidiary for the exclusive purpose of implementing, administering and managing Participant’s participation in this Agreement.

 

Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all Warrants or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing this Agreement.

 

Participant understands that Data will be transferred to a stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of this Agreement. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient’s country of operation (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing this Agreement to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing Participant’s participation in this Agreement. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in this Agreement. Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her engagement as a Service Provider and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant Warrants or other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant’s ability to participate in this Agreement. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.

 

 
-11-
 
 

 

19. Language . If Participant has received this Agreement or any other document related to the Warrant translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

 

20. Severability . In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect.

 

21. Entire Agreement; Governing Law . This Agreement, including the Employment Agreement which is incorporated herein by reference, constitutes the entire agreement of the parties with respect to the subject matter hereof and supersedes in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof, and may not be modified adversely to Participant’s interest except by means of a writing signed by the Company and Participant. This Agreement is governed by the internal substantive laws but not the choice of law rules of Nevada.

 

22. No Guarantee of Continued Service . PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS WARRANT OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.

 

( signature page follows )

 

 
-12-
 
 

 

By Participant’s signature and the signature of the Company’s representative below, Participant and the Company agree that this Warrant is granted under and governed by the terms and conditions of this Agreement. Participant has reviewed this Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing this Warrant and fully understands all provisions of this Warrant. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions relating to this Warrant. Participant further agrees to notify the Company upon any change in the residence address indicated below.

 

 

PARTICIPANT   LOOP INDUSTRIES, INC.  

 

 

 

 

   
Signature   By  
     

 

 

 

 

Print Name

 

Print Name

 

 

 

 

 

 

 

 

 

 

 

Title

 

 

 

 

 

 

 

 

 

Residence Address

 

 

 

 

 
-13-
 
 

 

EXHIBIT A

 

EXERCISE NOTICE

 

Loop Industries, Inc.

480, Fernand Poitras

Terrebonne, QC J6Y 1Y4

Canada

 

Attention: Stock Administration

 

1. Exercise of Warrant . Effective as of today, _____________, ____, the undersigned (“Participant”) hereby elects to exercise Participant’s compensatory warrant (the “Warrant”) to purchase ______________ shares of the Common Stock (the “Shares”) of Loop Industries, Inc. (the “Company”) under and pursuant to the Stand-Alone Compensatory Warrant Agreement dated ____________, _____ (the “Warrant Agreement”).

 

2. Delivery of Payment . Participant herewith delivers to the Company the full purchase price of the Shares, as set forth in the Warrant Agreement, and any and all withholding taxes due in connection with the exercise of the Warrant.

 

3. Representations of Participant . Participant acknowledges that Participant has received, read and understood the Warrant Agreement and agrees to abide by and be bound by its terms and conditions.

 

4. Rights as Stockholder . Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Shares subject to the Warrant, notwithstanding the exercise of the Warrant. The Shares so acquired shall be issued to Participant as soon as practicable after the Warrant is exercised in accordance with the Warrant Agreement. No adjustment shall be made for a dividend or other right for which the record date is prior to the date of issuance except as provided in Section 12 of the Warrant Agreement.

 

5. Tax Consultation . Participant understands that Participant may suffer adverse tax consequences as a result of Participant’s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of the Shares and that Participant is not relying on the Company for any tax advice.

 

 
-1-
 
 

 

6. Restrictive Legends and Stop-Transfer Orders .

 

(a) Legends . Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws:

 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.

 

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRIC-TIONS AND RIGHT OF FIRST REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES.

 

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY’S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER.

 

(b) Stop-Transfer Notices . Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

 

(c) Refusal to Transfer . The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

 

7. Successors and Assigns . The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.

 

 
-2-
 
 

 

8. Interpretation . Any dispute regarding the interpretation of this Exercise Notice shall be submitted by Participant or by the Company forthwith to the Board which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Board shall be final and binding on all parties.

 

9. Governing Law; Severability . This Exercise Notice is governed by the internal substantive laws but not the choice of law rules, of Nevada. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Exercise Notice shall continue in full force and effect.

 

10. Entire Agreement . The Warrant Agreement is incorporated herein by reference. This Exercise Notice, the Warrant Agreement and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant’s interest except by means of a writing signed by the Company and Participant.

 

 

Submitted by:

 

Accepted by:

 

 

 

 

 

PARTICIPANT   LOOP INDUSTRIES, INC.  

 

 

 

 

   
Signature   By  
     

 

 

 

 

Print Name

 

Print Name

 

 

 

 

 

 

 

 

 

 

 

Title

 

 

 

 

 

Address:

 

Address:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date Received

 

 

 
-3-
 
 

 

EXHIBIT B

 

INVESTMENT REPRESENTATION STATEMENT

 

PARTICIPANT :

 

 

 

COMPANY :

LOOP INDUSTRIES, INC.

 

 

SECURITY :

COMMON STOCK

 

 

AMOUNT :

 

 

 

DATE :

 

 

In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the Company the following:

 

(a) Participant is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).

 

(b) Participant acknowledges and understands that the Securities constitute “restricted securities” under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant’s investment intent as expressed herein. In this connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant’s representation was predicated solely upon a present intention to hold these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one (1) year or any other fixed period in the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws.

 

 
-1-
 
 

 

(c) Participant is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Warrant to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold, subject to the satisfaction of the applicable conditions specified by Rule 144, including in the case of affiliates (1) the availability of certain public information about the Company, (2) the amount of Securities being sold during any three (3) month period not exceeding specified limitations, (3) the resale being made in an unsolicited “broker’s transaction”, transactions directly with a “market maker” or “riskless principal transactions” (as those terms are defined under the Securities Exchange Act of 1934) and (4) the timely filing of a Form 144, if applicable.

 

In the event that the Company does not qualify under Rule 701 at the time of grant of the Warrant, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule 144, which may require (i) the availability of current public information about the Company; (ii) the resale to occur more than a specified period after the purchase and full payment (within the meaning of Rule 144) for the Securities; and (iii) in the case of the sale of Securities by an affiliate, the satisfaction of the conditions set forth in sections (2), (3) and (4) of the paragraph immediately above.

 

(d) Participant further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 shall have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can be given that any such other registration exemption shall be available in such event.

 

 

  PARTICIPANT
     

 

Signature  

 

 

 

   

 

Print Name

 

 

 

 

     

 

Date

 

 

 

-2-

 

EXHIBIT 10.2

 

LOOP CANADA INC.

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “ Agreement ”) is dated as of March 17, 2017, by and between Jennifer Rhee (“ Executive ”) and Loop Canada Inc. (the “ Company ”).

 

1. Duties .

 

1.1 Position . Executive is employed for the purpose of Chief Financial Officer to the Company, reporting to the Company’s President and Chief Executive Officer (the “ CEO ”). The duties and responsibilities of the Executive shall be commensurate with the position of an individual providing the same type of services in a similar company. The Executive shall perform such duties as from time to time may be prescribed for her by the CEO, in all cases to be consistent with Executive’s corporate offices and positions.

 

1.2 Obligations to the Company . Executive agrees to the best of her ability and experience that she will at all times loyally and conscientiously perform all of the duties and obligations required of and from Executive pursuant to the express and implicit terms hereof, and to the reasonable satisfaction of the Company. During the term of Executive’s employment relationship with the Company, Executive further agrees that she will devote all of her business time and attention to the business of the Company, the Company will be entitled to all of the benefits and profits arising from or incident to all such work services and advice, and Executive will not render commercial or professional services of any nature to any person or organization, whether or not for compensation, without the prior written consent of the CEO, and will not directly or indirectly engage or participate in any business that is competitive in any manner with the business of the Company. Executive will comply with and be bound by the Company’s operating policies, procedures and practices from time to time in effect during the term of Executive’s employment.

 

2. Term of Employment . Executive’s employment hereunder shall be for an indeterminate term and shall commence on April 3, 2017 (“ Commencement Date ”).

 

3. Compensation . For the duties and services to be performed by Executive hereunder, the Company shall pay Executive, and Executive agrees to accept, the salary and other benefits described below in this Section 3.

 

3.1 Salary . During the first two (2) years of employment, Executive shall receive a yearly base salary of $300,000. Executive’s salary will be payable pursuant to the Company’s normal payroll practices for payment of salary to executive employees. Following the first two (2) years of employment, Executive’s base salary will be reviewed as part of the Company’s normal salary review process, provided that the yearly base salary shall never be less than the previous year’s base salary.

 

 
1
 
 

 

3.2 Bonus and Other Additional Compensation . Subject to the terms and conditions that may be set out in Exhibit A attached hereto, Executive will be eligible to participate in such bonus plans as the Company may make available to its employees in its sole discretion or receive additional awards as may be set forth in Exhibit A attached hereto. The Company may cancel or modify the terms of such bonus plans from time to time. The annual bonus, if any, shall be paid between January 1 and March 15 of the calendar year that follows the bonus year. The Company and Executive shall agree upon goals and objectives to be required for Executive to meet to be eligible for payment of a bonus and such goals and objectives shall be set forth in Exhibit A attached hereto (or to be attached hereto) and incorporated herein by this reference. Exhibit A may be replaced, revised or updated from time to time by agreement of the parties.

 

3.3 Employee Benefit Plans . Executive shall participate in the employee benefit plans, programs and policies maintained by or for the Company for similarly situated employees in accordance with the terms and conditions to participate in such plans, programs and policies as in effect from time to time. The introduction and administration of benefit plans, programs and policies are within the Company’s sole discretion and the introduction, deletion or amendment of any benefit plan, program or policy will not constitute a breach of this Employment Agreement, provided the Executive is provided with substantially similar benefits or compensation in lieu.

 

3.4 Indemnification . Executive has previously entered into the Company’s standard form of Indemnification Agreement, attached hereto as Exhibit B, providing indemnification to Executive to the maximum extent permitted by law, and in accordance therewith, the Company has agreed to advance any expenses for which indemnification is available to the extent allowed by applicable law.

 

3.5 Vacation . Executive shall be eligible for 4 weeks of paid vacation as provided to similarly situated employees under the Company’s policy, if there is one, or other policies in place, which vacation time shall be taken at such time or times in each year so as not to materially and adversely interfere with the business of the Company. Unused vacation may not be carried over from any one-year period to any other period except as may be required by law.

 

3.6 Other Benefits . N/A

 

4. Severance Benefits . Executive shall be entitled to receive severance benefits upon termination of employment on the conditions set forth in this Section 4 or as may be required by applicable law. Executive’s entitlement to such severance benefits shall be conditioned upon Executive’s execution and delivery to the Company of (i) a mutual release of all claims within 15 days after termination and (ii) a resignation from all of Executive’s positions with the Company and such severance benefits shall be paid on the Payment Date as defined in Section 5.3 below. Any payment of severance benefits under the terms of this Agreement will be subject to all applicable tax withholding.

 

 
2
 
 

 

4.1 Voluntary Termination or Termination for Cause . If Executive voluntarily elects to terminate her employment with the Company other than by Executive’s Resignation for Good Reason, as defined in Section 5.4 below, or if the Company or a successor entity terminates Executive’s employment for Cause, as defined in Section 5.2 below, or the Executive dies or becomes incapacitated or otherwise disabled in such a manner that, in the sole determination of the CEO, the Executive cannot perform reasonably the duties specified in Section 1 above, then Executive will receive payment for all salary and unpaid vacation accrued as of the date of Executive’s termination of employment and Executive’s benefits, as applicable, will be continued solely to the extent of the Company’s then existing benefit plans and policies in accordance with such plans and policies in effect on the date of termination and in accordance with applicable law (together, the “ Other Benefits ”) and the Company shall not have any further obligation to Executive.

 

4.2 Involuntary Termination . If Executive’s employment is terminated by the Company or a successor entity without Cause or by Executive’s Resignation for Good Reason, Executive will receive the Other Benefits and continued payment of her base salary for a period equal to the greater of six (6) months or one (1) month per year of service with the Company. For greater certainty, any option or warrants or rights to other compensation or equity, as may be set out in Exhibit A or otherwise acquired, that remains unvested or has not yet been earned at the time of Executive’s termination shall terminate immediately upon Executive’s termination of employment.

 

4.3 Change of Control . In the event of a Change of Control, all of the Executive’s unvested options, shares or other equity shall immediately vest.

 

5. Definitions . For purposes of this Agreement, the following definitions shall apply:

 

5.1 “ Change of Control ” means a sale of all or substantially all of the assets of the Company or its parent, LOOP Industries, Inc. (“ LPP ”), or any merger or consolidation of either the Company or LPP with or into another corporation other than a merger or consolidation in which the holders of more than 50% of the shares of capital stock of the Company or LPP (as the case may be) outstanding immediately prior to such transaction continue to hold (either by the voting securities remaining outstanding or by their being converted into voting securities of the surviving entity) more than 50% of the total voting power represented by the voting securities of the Company or LPP (as the case may be), or such surviving entity, outstanding immediately after such transaction.

 

5.2 “ Cause ” means a serious reason pursuant to Article 2094 of the Civil Code of Quebec and includes, without limitation, (a) Executive’s breach of a material term of this Agreement; (b) Executive’s conviction of a criminal offence involving fraud or dishonesty, or which otherwise adversely impacts the reputation of the Company; (c) Executive or any member of Executive’s immediate family making personal profit out of or in connection with a transaction or business opportunity to which the Company is involved or otherwise associated with, without making disclosure to and seeking the prior written consent of the Company; (d) Executive’s failure to comply with any Company rules or policies of a material nature; (e) prior to a Change of Control, Executive’s continued failure to substantially perform her job duties, which is not cured within ten (10) calendar days of receiving written notice of such failure from the Company; (f) any actions or omissions on Executive’s part constituting gross misconduct or negligence in connection with the business of the Company.

 

 
3
 
 

 

5.3 “ Payment Date ” means the tenth business day following effectiveness of the release of claims described in Section 4; provided however, if the 60 th day following termination of employment falls in a subsequent calendar year, then the Payment Date shall be the later of (i) the first business day of such subsequent calendar year and (ii) the tenth business day following effectiveness of the release.

 

5.4 “ Resignation for Good Reason ” means, subject to the right of either party to arbitrate a dispute with respect thereto in accordance with Section 12 below, Executive’s resignation as a result of, and within 30 days following: (i) a significant and substantial reduction in Executive’s job, duties, or responsibilities in a manner that is substantially and materially inconsistent with the position, duties, or responsibilities held by Executive immediately before such reduction; (ii) any reduction in Executive’s base salary other than in connection with and consistent with a general reduction of all officer base salaries; or (iii) a relocation of the Executive’s work location to a location more than 50 kilometers away from their current location provided such change increases Executive’s commute by 25 kilometers or 30 minutes. In each case, Executive shall give written notice to the Company of such event, and allow the Company a reasonable period to cure such event.

 

6. Confidentiality Agreement . Executive has signed a Proprietary Information and Inventions Agreement (the “ Proprietary Agreement ”) that is incorporated by reference and made a part of this Agreement and the form of which is attached hereto as Exhibit C. Executive hereby represents and warrants to the Company that Executive has complied with all obligations under the Proprietary Agreement and agrees to continue to abide by the terms of the Proprietary Agreement and further agrees that the provisions of the Proprietary Agreement shall survive any termination of this Agreement or of Executive’s employment relationship with the Company in accordance with the terms of the Proprietary Agreement.

 

7. Confidentiality of Terms . Executive agrees to follow the Company’s strict policy that employees must not disclose, either directly or indirectly, any information, including any of the terms of this Agreement, regarding salary or stock purchase allocations to any person, including other employees of the Company (other than such employees who have a need to know such information); provided, however, that Executive may discuss such terms with members of her immediate family and any legal, tax or accounting specialists who provide Executive with individual legal, tax or accounting advice.

 

8. Covenants . In addition to the obligations to which the Executive agreed by executing the Proprietary Agreement, Executive understands and agrees that during the term of Executive’s employment with the Company, and for the greater of (i) the duration of any payments to Executive of severance benefits pursuant to Section 4 of this Agreement or (ii) one (1) year after the termination of Executive’s employment with the Company, Executive will not do any of the following:

 

8.1 Compete . Without the Company’s prior written consent, within the Province of Quebec, directly or indirectly be employed or involved with any business developing or exploiting any products or services that are competitive with products or services (i) being commercially developed or exploited by the Company during Executive’s employment and (ii) on which Executive worked or about which Executive learned proprietary information or trade secrets of the Company during Executive’s employment with the Company.

 

 
4
 
 

 

8.2 Solicit Business . Solicit or influence or attempt to influence any client, customer or other person either directly or indirectly, to direct his, her or its purchase of the Company’s products and/or services to any person, firm, corporation, institution or other entity in competition with the business of the Company.

 

8.3 Solicit Personnel . Solicit or influence or attempt to influence any of the Company’s employees, consultants or other service providers to terminate or otherwise cease his, her or its employment, consulting or service relationships with the Company or to become an employee, consultant or service provider of any competitor of the Company.

 

9. Breach of the Agreement . Executive acknowledges that upon her breach of this Agreement or the Proprietary Agreement, the Company would sustain irreparable harm from such breach, and, therefore, Executive agrees that in addition to any other remedies which the Company may have under this Agreement or otherwise, the Company shall be entitled to obtain equitable relief, including specific performance and injunctions, restraining Executive from committing or continuing any such violation of the Agreement or the Proprietary Agreement. Executive acknowledges and agrees that upon Executive’s material or intentional breach of any of the provisions of the Agreement (including Section 8) or the Proprietary Agreement, in addition to any other remedies the Company may have under this Agreement or otherwise, the Company’s obligations to provide benefits to Executive as described in this Agreement, including without limitation those benefits provided in Section 4, shall immediately terminate, except as required by applicable law.

 

10. Entire Agreement . This Agreement, including the Proprietary Agreement that the Executive has signed, sets forth the entire agreement and understanding of the parties relating to the subject matter herein, supersedes any prior agreement, and merges all prior discussions between them.

 

11. Conflicts . Executive represents and warrants that her performance of all the terms of this Agreement will not breach any other agreement or understanding to which Executive is a party. Executive has not, and will not during the term of this Agreement, enter into any oral or written agreement in conflict with any of the provisions of this Agreement.

 

12. Dispute Resolution . In the event of any dispute, controversy or claim arising under or in connection with this Agreement, or the breach hereof (including a dispute as to whether Cause or Resignation for Good Reason exists), the parties hereto shall first submit their dispute to formal mediation. The Company shall select a mediator reasonably acceptable to both parties. In the event that the parties cannot reach resolution through formal mediation, the dispute shall be settled by arbitration in the city of Montreal, in accordance with the Rules of the Quebec Code of Civil Procedure then in effect. Each party shall pay his, her or its own costs (including attorneys’ fees) in connection with such mediation or arbitration. To the extent such mediation or arbitration requires the submission of any information that either party claims is confidential information, the parties agree that such mediation or arbitration shall be confidential proceeding. Judgment upon the award rendered by the mediator or arbitrator may be entered in any court of competent jurisdiction. If any proceeding is necessary to enforce the mediation or arbitration award, the prevailing party shall be entitled to reasonable attorneys’ fees and costs and disbursements, in addition to any other relief to which such party may be entitled. Notwithstanding the foregoing, the Company shall be entitled to seek equitable relief directly from a court of competent jurisdiction (without prior arbitration) with respect to any alleged breach of the Proprietary Agreement or Section 8, including specific performance and injunctions, restraining Executive from committing or continuing to commit such alleged breach.

 

 
5
 
 

 

13. Successors . Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under this Agreement and agrees expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. The terms of this Agreement and all of Executive’s rights hereunder shall inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

 

14. Miscellaneous Provisions .

 

14.1 Amendments and Waivers . Any term of this Agreement may be amended or waived only with the written consent of the parties. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

 

14.2 Notices . Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon receipt, when delivered personally or by a nationally-recognized delivery service (such as Federal Express or UPS), or 48 hours after being deposited in the mail as certified or registered mail with postage prepaid, if such notice is addressed to the party to be notified at such party’s address as set forth below or as subsequently modified by written notice.

 

14.3 Choice of Law . The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the Province of Quebec, without giving effect to its or any other jurisdiction’s principles of conflict of laws.

 

14.4 Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.

 

14.5 Counterparts . This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.

 

14.6 Advice of Counsel . Each party to this agreement acknowledges that, in executing this Agreement, such party has had the opportunity to seek the advice of independent legal counsel, and has read and understood all of the terms and provisions of this Agreement. This Agreement shall not be construed against any party by reason of the drafting of preparation hereof.

 

[Signature page follows.]

 

 
6
 
 

 

The parties have executed this Employment Agreement as of the date first written above.

 

 

 

The Company:

 

 

 

 

  LOOP CANADA INC.
       
By: /s/ Daniel Solomita

 

 

Daniel Solomita  
   

President and Chief Executive Officer

 
       

 

Executive:

 

 

 

 

 

 

By:

/s/ Jennifer Rhee

 

 

Name:

Jennifer Rhee

 

 

 

 

 

 

Address:

119 Laurier St.

Dollard-Des-Ormeaux, Qc

H9B 3B1

 

 

 
7
 
 

 

EXHIBIT A

 

· Issuance of 400,000 warrants to purchase common stock of Loop Industries, Inc. with a strike price of $5.25 that vests quarterly equally over the 24 months following the Commencement Date

 

 

· Issuance of 50,000 warrants to purchase common stock of Loop Industries, Inc. with a strike price of $5.25 that vests fully at the completion of the first full scale production facility producing a minimum of 10,000 M/T per year of PTA & MEG

 

 

· Issuance of 50,000 warrants to purchase common stock of Loop Industries, Inc. with a strike price of $5.25 that vests fully once the Company delivers a minimum of 10,000 M/T of PTA or MEG or PET to a commercial client

 

 

· Issuance of 50,000 warrants to purchase common stock of Loop Industries, Inc. with a strike price of $5.25 that vests fully at the completion of the second full scale production facility producing a minimum of 40,000 M/T per year of PTA & MEG

 

 
8
 
 

 

EXHIBIT B

 

INDEMNIFICATION AGREEMENT

 

 

 

 

 

 
9
 
 

 

EXHIBIT C

 

PROPRIETARY INFORMATION AND

INVENTIONS AGREEMENT

 

LOOP CANADA INC.

 

 

 

 

10

 

EXHIBIT 31.1

 

SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER OF LOOP INDUSTRIES, INC.

 

I, Daniel Solomita, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;

 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: July 14, 2017

By:

/s/ Daniel Solomita

 

 

 

Daniel Solomita

 

 

 

President and Chief Executive Officer (principal executive officer)

 

 

EXHIBIT 31.2

 

SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF LOOP INDUSTRIES, INC.

 

I, D. Jennifer Rhee, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;

 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: July 14, 2017

By:

/s/ D. Jennifer Rhee

 

 

 

D. Jennifer Rhee

 

 

 

Chief Financial Officer (principal financial officer and principal accounting officer)

 

 

EXHIBIT 32.1

 

SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER OF LOOP INDUSTRIES, INC.

 

In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended May 31, 2017, the undersigned, Daniel Solomita, President and Chief Executive Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) such Quarterly Report on Form 10-Q for the quarter ended May 31, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2) the information contained in such Quarterly Report on Form 10-Q for the quarter ended May 31, 2017, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.

 

 

Date: July 14, 2017

By:

/s/ Daniel Solomita

 

 

 

Daniel Solomita

 

 

 

President and Chief Executive Officer (principal executive officer)

 

 

EXHIBIT 32.2

 

SECTION 906 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF LOOP INDUSTRIES, INC.

 

In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended May 31, 2017, the undersigned, D. Jennifer Rhee, Chief Financial Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) such Quarterly Report on Form 10-Q for the quarter ended May 31, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2) the information contained in such Quarterly Report on Form 10-Q for the quarter ended May 31, 2017, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.

 

 

Date: July 14, 2017

By:

/s/ D. Jennifer Rhee

 

 

 

D. Jennifer Rhee

 

 

 

Chief Financial Officer (principal financial officer and principal accounting officer)